LRRK2 and Parkinson disease: Mutations and single‐nucleotide polymorphisms in the kinase leucine‐rich repeat kinase 2 (LRRK2) are associated with an increased risk of Parkinson's disease (PD) or Crohn's disease (Ferreira & Massano, 2017).